Login

Ryu Young-sang, CEO of SK Telecom, speaks with CNBC's Arjun Kharpal at Mobile World Congress in Barcelona, Spain. 00:10:00

Share On Facebook Share On Twitter

Ryu Young Sang "James". President/CEO, SK Telecom Co Ltd

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Generative AI Truly Reshaping Business|Danel Dayan,Venture Capital Investor,Battery Ventures
00:10:00
Performance and Strategy Insights: Alliance Trust in 2023 | Craig Baker, CIO , Alliance Trust.
00:10:00
Group CEO of Córas Iompair Éireann (CIE), Bruce Heppenstall, and Plant Director of Drax Group plc, David Johnson, discuss collaborative initiatives in energy and security.
00:10:00
Apollo's Path to Dominance in Alternative Investments | Marc Rowan, CEO, Apollo Global Management.
00:10:00
Focus exclusively on founders starting companies that are pre-traction|Anamitra Banerji,Managing Director, Afore Capital
00:10:00
Economic Futures: Robert Swaak at Impact Nation Live - ABN AMRO | Robert Swaak, CEO , ABN AMRO.
00:10:00
Chrysos Corp 1H FY24 Webcast Highlights | Brett Coventry, Chief Financial Officer of Chrysos Corporation Limited
00:10:00
Understanding the Current Rise in Electricity Prices | Rolf Barmen, CEO, Elmera Group ASA.
00:10:00
Interview with Doug Gruer, CEO of Emu NL on Assay TV
00:10:00
Alexandria Minerals: Revitalizing Gold Exploration in Val-d'Or, Quebec
00:10:00
American West Metals Prepares for Drilling at Storm Copper Project in Canada | Philippe Guillemot, CEO, American West Metals Ltd.
00:10:00
Insights from the Top: Pascal Juéry Discusses Agfa Gevaert's Future | Pascal Juéry - President and Chief Executive Officer of Agfa-Gevaert

© 2017 - Neuhu+